Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
AMISULPRIDE
B & S Healthcare
N05AL05
AMISULPRIDE
200 Milligram
Tablets
Product subject to prescription which may be renewed (B)
Antipsychotics
Authorised
2012-10-19
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Solian 200mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each Solian 200mg tablet contains 200mg amisulpride Also contains lactose monohydrate. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet _Product imported from Italy._ White to off-white round, flat-faced, breakable tablet engraved 'AMI 200' on one face and with a breakable bar on the other face. The scoreline/ breakline is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS As per PA0540/158/003 5 PHARMACOLOGICAL PROPERTIES As per PA0540/158/003 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Sodium starch glycolate (type A) Lactose monohydrate Microcrystalline cellulose Hypromellose Magnesium stearate 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE No special storage conditions. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 23/03/2015_ _CRN 2158713_ _page number: 1_ 6.5 NATURE AND CONTENTS OF CONTAINER Blister pack of 30 tablets in an over labelled outer carton 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special precautions 7 PARALLEL PRODUCT AUTHORISATION HOLDER B&S Healthcare Unit 4 Bradfield Road Ruislip Middlesex HA4 0NU United Kingdom 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1328/176/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisati Прочитать полный документ